Smith & Nephew plc (SNN)
NYSE: SNN · IEX Real-Time Price · USD
24.14
+0.01 (0.04%)
At close: May 1, 2024, 4:00 PM
24.55
+0.41 (1.70%)
Pre-market: May 2, 2024, 7:03 AM EDT
Smith & Nephew Revenue
In the year 2023, Smith & Nephew had annual revenue of $5.55B with 6.40% growth.
Revenue (ttm)
$5.55B
Revenue Growth
+6.47%
P/S Ratio
1.90
Revenue / Employee
$290,813
Employees
19,081
Market Cap
10.52B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
Dec 31, 2018 | 4.90B | 139.00M | 2.92% |
Dec 31, 2017 | 4.77B | 96.00M | 2.06% |
Dec 31, 2016 | 4.67B | 35.00M | 0.76% |
Dec 31, 2015 | 4.63B | 17.00M | 0.37% |
Dec 31, 2014 | 4.62B | 266.00M | 6.11% |
Dec 31, 2013 | 4.35B | 214.00M | 5.17% |
Dec 31, 2012 | 4.14B | -133.00M | -3.11% |
Dec 31, 2011 | 4.27B | 308.00M | 7.77% |
Dec 31, 2010 | 3.96B | 190.00M | 5.04% |
Dec 31, 2009 | 3.77B | -29.00M | -0.76% |
Dec 31, 2008 | 3.80B | 432.00M | 12.82% |
Dec 31, 2007 | 3.37B | 590.00M | 21.23% |
Dec 31, 2006 | 2.78B | 227.00M | 8.89% |
Dec 31, 2005 | 2.55B | 251.00M | 10.91% |
Dec 31, 2004 | 2.30B | 1.12B | 95.17% |
Dec 31, 2003 | 1.18B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.56B |
Universal Health Services | 14.28B |
Solventum | 8.20B |
Catalent | 4.10B |
Incyte | 3.70B |
Bruker | 2.96B |
Exact Sciences | 2.50B |
United Therapeutics | 2.33B |
SNN News
- 23 days ago - Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia - GlobeNewsWire
- 27 days ago - Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE) - GlobeNewsWire
- 4 weeks ago - Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds - GlobeNewsWire
- 5 weeks ago - Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner - GlobeNewsWire
- 2 months ago - Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting - GlobeNewsWire
- 3 months ago - Australia's approach to musculoskeletal injury care and reimbursement demands rethink: Report - GlobeNewsWire